drugset / Trial / NCT01411124
Study to Assess the Effect of Gabapentin Enacarbil on Simulated Driving in Healthy Subjects
RandomizedCrossoverQuadruple-blindTreatment
Summary
This is a double-blind, placebo-and active-controlled 3-period crossover study designed to assess the effect of GEn 600 mg on simulated driving performance in healthy volunteers.
Timeline
- Start
- 2011-06
- Primary completion
- 2011-10
- Completion
- 2011-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Diphenhydramine | Unknown | 50 mg | — |
| Subject | gabapentin enacarbil | Small molecule | 600 mg | — |